Laparoscopic Splenectomy

Since the first description of laparoscopic splenectomy (LS) in 1991, this technique has been adopted as the standard procedure for most indications for splenectomy throughout the world. The utility of LS in the treatment of hematologic diseases such as hereditary spherocytosis, immune thrombocytopenic purpura, and autoimmune hemolytic anemia is well established. LS has become the gold standard approach for normal or slightly enlarged spleens and is currently considered the procedure of choice. The benefits of laparoscopic removal of the spleen are evident to patients and surgeons alike. This approach is superior to open splenectomy in terms of postoperative pain, shorter postoperative hospital stay, perioperative complications, and an improved cosmetic result. Additionally, the period of convalescence is brief, with an early return to work or normal activities. The results of large series around the world are similar, with an operating time of between 60 and 90 minutes, hospital stay of between 1 and 2 days and morbidity of less than 10% [1,2,3,4,5].